Table 2b.
Incidence rate ratios for new onset hypertension stratified by race
| Among Blacks | Among non-Blacks | ||||||
|---|---|---|---|---|---|---|---|
| IRR | 95% CI | p | IRR | 95% CI | p | ||
| Stable donor (17/82) vs. stable ND (356/1,449) | 1.34 | 0.73–2.45 | 0.35 | Stable donor (125/659) vs. stable ND (621/2,701) | 0.98 | 0.72–1.33 | 0.90 |
| Donor loss >5% (4/28) vs. stable ND | 0.77 | 0.25–3.40 | 0.65 | Donor loss >5% (18/150) vs. stable ND | 0.53 | 0.30–0.94 | 0.03 |
| Donor gain >5% (15/39) vs. stable ND | 3.08 | 1.45–6.54 | 0.003 | Donor gain >5% (86/276) vs. stable ND | 1.99 | 1.36–2.76 | < 0.001 |
| ND loss >5% (42/203) vs. stable ND | 0.77 | 0.52–1.13 | 0.18 | ND loss > 5% (84/409) vs. stable ND | 0.81 | 0.62–1.06 | 0.13 |
| ND gain >5% (219/730) vs. stable ND | 1.26 | 0.99–1.61 | 0.06 | ND gain >5% (323/1,119) vs. stable ND | 1.23 | 1.03–1.46 | 0.02 |
| Donor loss >5% vs. ND loss > 5% | 1.00 | 0.30–3.30 | 0.99 | Donor loss >5% vs. ND loss > 5% | 0.66 | 0.36–1.21 | 0.18 |
| Donor gain >5% vs. ND gain >5% | 2.44 | 1.13–5.26 | 0.02 | Donor gain >5% vs. ND gain >5% | 1.58 | 1.08–2.29 | 0.02 |
| Enrollment year | 0.96 | 0.94–0.97 | < 0.001 | Enrollment year | 0.98 | 0.97–0.99 | 0.001 |
| Observations | 2,531 | Observations | 5,394 | ||||
| Donors | 96 | Donors | 624 | ||||
| Non-donors | 1,189 | Non-donors | 1,726 | ||||